These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23509295)

  • 21. Stargardt-like macular dystrophy protein ELOVL4 exerts a dominant negative effect by recruiting wild-type protein into aggresomes.
    Vasireddy V; Vijayasarathy C; Huang J; Wang XF; Jablonski MM; Petty HR; Sieving PA; Ayyagari R
    Mol Vis; 2005 Aug; 11():665-76. PubMed ID: 16163264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel mutation in the ELOVL4 gene causes autosomal dominant Stargardt-like macular dystrophy.
    Maugeri A; Meire F; Hoyng CB; Vink C; Van Regemorter N; Karan G; Yang Z; Cremers FP; Zhang K
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4263-7. PubMed ID: 15557430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids.
    Agbaga MP; Brush RS; Mandal MN; Henry K; Elliott MH; Anderson RE
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12843-8. PubMed ID: 18728184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Elovl4 Spinocerebellar Ataxia-34 Mutation 736T>G (p.W246G) Impairs Retinal Function in the Absence of Photoreceptor Degeneration.
    Agbaga MP; Stiles MA; Brush RS; Sullivan MT; Machalinski A; Jones KL; Anderson RE; Sherry DM
    Mol Neurobiol; 2020 Nov; 57(11):4735-4753. PubMed ID: 32780351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of ER retention and sequestration of the wild-type ELOVL4 by Stargardt disease dominant negative mutants.
    Karan G; Yang Z; Howes K; Zhao Y; Chen Y; Cameron DJ; Lin Y; Pearson E; Zhang K
    Mol Vis; 2005 Aug; 11():657-64. PubMed ID: 16145543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Very long chain polyunsaturated fatty acids and rod cell structure and function.
    Marchette LD; Sherry DM; Brush RS; Chan M; Wen Y; Wang J; Ash JD; Anderson RE; Mandal NA
    Adv Exp Med Biol; 2014; 801():637-45. PubMed ID: 24664753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DHA does not protect ELOVL4 transgenic mice from retinal degeneration.
    Li F; Marchette LD; Brush RS; Elliott MH; Le YZ; Henry KA; Anderson AG; Zhao C; Sun X; Zhang K; Anderson RE
    Mol Vis; 2009 Jun; 15():1185-93. PubMed ID: 19536303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ELOVL4: Very long-chain fatty acids serve an eclectic role in mammalian health and function.
    Hopiavuori BR; Anderson RE; Agbaga MP
    Prog Retin Eye Res; 2019 Mar; 69():137-158. PubMed ID: 30982505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homozygous Expression of Mutant ELOVL4 Leads to Seizures and Death in a Novel Animal Model of Very Long-Chain Fatty Acid Deficiency.
    Hopiavuori BR; Deák F; Wilkerson JL; Brush RS; Rocha-Hopiavuori NA; Hopiavuori AR; Ozan KG; Sullivan MT; Wren JD; Georgescu C; Szweda L; Awasthi V; Towner R; Sherry DM; Anderson RE; Agbaga MP
    Mol Neurobiol; 2018 Feb; 55(2):1795-1813. PubMed ID: 29168048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Essential role of ELOVL4 protein in very long chain fatty acid synthesis and retinal function.
    Harkewicz R; Du H; Tong Z; Alkuraya H; Bedell M; Sun W; Wang X; Hsu YH; Esteve-Rudd J; Hughes G; Su Z; Zhang M; Lopes VS; Molday RS; Williams DS; Dennis EA; Zhang K
    J Biol Chem; 2012 Mar; 287(14):11469-80. PubMed ID: 22199362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elovl4 5-bp deletion knock-in mouse model for Stargardt-like macular degeneration demonstrates accumulation of ELOVL4 and lipofuscin.
    Vasireddy V; Jablonski MM; Khan NW; Wang XF; Sahu P; Sparrow JR; Ayyagari R
    Exp Eye Res; 2009 Dec; 89(6):905-12. PubMed ID: 19682985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different Mutations in ELOVL4 Affect Very Long Chain Fatty Acid Biosynthesis to Cause Variable Neurological Disorders in Humans.
    Agbaga MP
    Adv Exp Med Biol; 2016; 854():129-35. PubMed ID: 26427403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermal expression of an Elovl4 transgene rescues neonatal lethality of homozygous Stargardt disease-3 mice.
    McMahon A; Butovich IA; Kedzierski W
    J Lipid Res; 2011 Jun; 52(6):1128-1138. PubMed ID: 21429867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elovl4 haploinsufficiency does not induce early onset retinal degeneration in mice.
    Li W; Chen Y; Cameron DJ; Wang C; Karan G; Yang Z; Zhao Y; Pearson E; Chen H; Deng C; Howes K; Zhang K
    Vision Res; 2007 Mar; 47(5):714-22. PubMed ID: 17254625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy.
    Zhang K; Kniazeva M; Han M; Li W; Yu Z; Yang Z; Li Y; Metzker ML; Allikmets R; Zack DJ; Kakuk LE; Lagali PS; Wong PW; MacDonald IM; Sieving PA; Figueroa DJ; Austin CP; Gould RJ; Ayyagari R; Petrukhin K
    Nat Genet; 2001 Jan; 27(1):89-93. PubMed ID: 11138005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4.
    McMahon A; Butovich IA; Mata NL; Klein M; Ritter R; Richardson J; Birch DG; Edwards AO; Kedzierski W
    Mol Vis; 2007 Feb; 13():258-72. PubMed ID: 17356513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of wild type and mutant ELOVL4 in cell culture: subcellular localization and cell viability.
    Karan G; Yang Z; Zhang K
    Mol Vis; 2004 Mar; 10():248-53. PubMed ID: 15073583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Very long chain fatty acid-containing lipids: a decade of novel insights from the study of ELOVL4.
    Yeboah GK; Lobanova ES; Brush RS; Agbaga MP
    J Lipid Res; 2021; 62():100030. PubMed ID: 33556440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Cellular Functions of Very Long Chain-Fatty Acids: Insight From ELOVL4 Mutations.
    Deák F; Anderson RE; Fessler JL; Sherry DM
    Front Cell Neurosci; 2019; 13():428. PubMed ID: 31616255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haploinsufficiency is not the key mechanism of pathogenesis in a heterozygous Elovl4 knockout mouse model of STGD3 disease.
    Raz-Prag D; Ayyagari R; Fariss RN; Mandal MN; Vasireddy V; Majchrzak S; Webber AL; Bush RA; Salem N; Petrukhin K; Sieving PA
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3603-11. PubMed ID: 16877435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.